Insufficient scRNA-seq data for expression of IL22 at single-cell level.
Insufficient scRNA-seq data for expression of IL22 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| spleen | 47% | 1.99 | 114 / 241 | 0% | 0 | 0 / 0 |
| intestine | 27% | 4.60 | 260 / 966 | 5% | 0.10 | 28 / 527 |
| lung | 31% | 2.74 | 180 / 578 | 1% | 0.01 | 7 / 1155 |
| peripheral blood | 29% | 1.24 | 270 / 929 | 0% | 0 | 0 / 0 |
| esophagus | 21% | 6.33 | 302 / 1445 | 3% | 0.06 | 6 / 183 |
| brain | 20% | 1.30 | 518 / 2642 | 0% | 0.02 | 3 / 705 |
| stomach | 13% | 0.59 | 46 / 359 | 5% | 0.11 | 15 / 286 |
| bladder | 14% | 0.29 | 3 / 21 | 3% | 0.06 | 13 / 504 |
| adipose | 16% | 1.28 | 198 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 14% | 0.65 | 192 / 1335 | 0% | 0 | 0 / 0 |
| skin | 13% | 0.74 | 230 / 1809 | 0% | 0 | 0 / 472 |
| thymus | 9% | 0.30 | 60 / 653 | 0% | 0 | 0 / 605 |
| breast | 8% | 0.42 | 39 / 459 | 0% | 0.00 | 2 / 1118 |
| heart | 8% | 0.40 | 71 / 861 | 0% | 0 | 0 / 0 |
| muscle | 8% | 0.20 | 64 / 803 | 0% | 0 | 0 / 0 |
| prostate | 7% | 0.22 | 18 / 245 | 0% | 0 | 0 / 502 |
| ovary | 7% | 0.27 | 12 / 180 | 0% | 0.01 | 2 / 430 |
| uterus | 6% | 0.15 | 10 / 170 | 0% | 0 | 0 / 459 |
| kidney | 6% | 0.16 | 5 / 89 | 0% | 0.01 | 2 / 901 |
| liver | 5% | 0.13 | 11 / 226 | 0% | 0 | 0 / 406 |
| adrenal gland | 2% | 0.04 | 5 / 258 | 0% | 0 | 0 / 230 |
| pancreas | 2% | 0.04 | 6 / 328 | 0% | 0 | 0 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0050728 | Biological process | negative regulation of inflammatory response |
| GO_0006953 | Biological process | acute-phase response |
| GO_0006954 | Biological process | inflammatory response |
| GO_0051384 | Biological process | response to glucocorticoid |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0045518 | Molecular function | interleukin-22 receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005125 | Molecular function | cytokine activity |
| Gene name | IL22 |
| Protein name | Interleukin-22 (IL-22) (Cytokine Zcyto18) (IL-10-related T-cell-derived-inducible factor) (IL-TIF) Interferon 2B1 (Interleukin 22) Interleukin 22 |
| Synonyms | ILTIF IF2B1 UNQ3099/PRO10096 ZCYTO18 hCG_15986 |
| Description | FUNCTION: Cytokine that plays a critical role in modulating tissue responses during inflammation . Plays an essential role in the regeneration of epithelial cells to maintain barrier function after injury and for the prevention of further tissue damage . Unlike most of the cytokines, has no effect on immune cells. Signals through a heterodimeric receptor composed of two subunits, the specific receptor IL22RA1 which is present on non-immune cells in many organs and the shared subunit IL10RB . Ligation of IL22RA1 with IL22 induces activation of the tyrosine kinases JAK1 and TYK2, which in turn activates STAT3. In turn, promotes cell survival and proliferation through STAT3, ERK1/2 and PI3K/AKT pathways . Promotes phosphorylation of GSK3B at 'Ser-9' and CTTN (By similarity). Promotes epithelial cell spreading (By similarity). . |
| Accessions | A0A7R8C389 Q6NZ84 ENST00000328087.6 Q6NWP4 ENST00000538666.6 Q6NZ83 Q9GZX6 |